Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patient With Exacerbation of Pulmonary Infection.

Trial Profile

Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patient With Exacerbation of Pulmonary Infection.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Jan 2014

At a glance

  • Drugs Meropenem (Primary)
  • Indications Bacterial infections; Cystic fibrosis-associated respiratory tract infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 06 Jun 2012 Planned End Date 1 Aug 2012 added as reported by ClinicalTrials.gov.
    • 21 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top